CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
GORE® VIABIL® Biliary Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01343160
NCT01343160N/ACompleted
CompareCT.gov

Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

W.L.Gore & Associates·interventional·Posted Apr 27, 2011·Updated Apr 21, 2021

In Brief

A clinical study evaluating GORE® VIABIL® Biliary Endoprosthesis for Biliary Strictures. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The purpose of this study is to generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBiliary Strictures
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 27, 2011
Enrollment StartApr 1, 2011
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 15.2 years ago

Interventions

GORE® VIABIL® Biliary Endoprosthesisdevice

Deployment of GORE® VIABIL® Biliary Endoprosthesis to the area of stricture